Advertisement

Clinical Features of Human T-Cell Leukemia/Lymphoma Virus (HTLV) Associated T-Cell Neoplasms

  • Hiroaki Mitsuya
  • Samuel Broder

Abstract

Approximately seven years ago clinical investigators in Kyoto reported a rapidly fatal T-cell lymphoproliferative syndrome, which seemed to affect adult populations born in the Southwestern part of the Japanese archipelago, even though the population may have migrated to another area of Japan. They referred to this disease as adult T-cell leukemia, and to date over 300 patients have been described by several groups in Japan. The syndrome is characterized by the presence of pleomorphic neoplastic cells with the membrane markers of mature T-lymphocytes. Several other findings are common at presentation including lymphadenopathy, hepatomegaly, splenomegaly, cutaneous infiltration with neoplastic T cells, hypercalcemia (with or without lytic bone lesions), and interstitial pulmonary infiltrates. Characteristically, there was an absence of mediastinal tumor involvement.

Keywords

Mycosis Fungoides Lytic Bone Lesion Acquire Immunodeficiency Disease Syndrome Cell Lymphoblastic Lymphoma Interstitial Pulmonary Infiltrate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    E. L. Reinherz, P. C. Kung, G. Goldstein, R. H. Levey, and S. F. Schlossman, Discrete stages of human intrathymic differentiation: Analysis of normal thymocytes and leukemic lymphoblasts of T cell lineage, PNAS 77: 1588 (1980).Google Scholar
  2. 2.
    E. L. Reinherz, P. C. Kung, G. Goldstein, and S. F. Schlossman, A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells, J. Immunol. 123: 1312 (1979).PubMedGoogle Scholar
  3. 3.
    E. L. Reinherz and S. F. Schlossman, The characterization and function of human immunoregulatory T lymphocyte subsets, Immunology Today 2: 69 (1981).CrossRefGoogle Scholar
  4. 4.
    W. Verbi, M. F. Greaves, C. Schneider, K. Koubeck, G. Janossy, H. Stein, P. Kung, and G. Goldstein, Monoclonal antibodies OKT11 and OKT11A have pan-t reactivity and block sheep erythrocyte “receptors.” Eur. J. Immunol 12: 81 (1982).PubMedCrossRefGoogle Scholar
  5. 5.
    T. Uchiyama, S. Broder, and T. A. Waldmann, A monoclonal antibody (anti-Tac) reactive with activated and functionally mature T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac T cells, J. Immunol. 126: 1393 (1981).PubMedGoogle Scholar
  6. 6.
    S. Broder, R. L. Edelson, M. A. Lutzner, D. L. Nelson, R. P. MacDermott, R.P., M. E. Dunn, C. K. Goldman, D. B. Meade, and T. A. Waldmann, Sezary syndrome: A malignant proliferation of helper T cells, J. Clin. Invest. 58: 1297 (1976).PubMedCrossRefGoogle Scholar
  7. 7.
    P. A. Bunn and S. I. Lamberg, Report of the committee on staging and classification of cutaneous T-cell lymphomas, Cancer Treat. Rep. 63: 725 (1979).PubMedGoogle Scholar
  8. 8.
    J. Cossman, T. M. Chused, R. I. Fisher, I. Magrath, F. Bollum,and E. S. Jaffe, Diversity of immunologic phenotypes of lymphoblastic lymphoma, Cancer Res. 43: 4486 (1983).PubMedGoogle Scholar
  9. 9.
    T. A. Waldmann, S. Broder, W. C. Greene, P. S. Sarin, D. Blayney, C. K. Goldman, K. Frost, S. Sharrow, J. Depper, W. Leonard, T. Uchiyama, and R. Gallo, A comparison of the function and phenotype of Sezary T cells with human T cell leukemia/ lymphoma virus (HTLV)-associated adult T cell leukemia, (submitted) (1983).Google Scholar
  10. 10.
    J. F. Gootenberg, F. W. Ruscetti, J. W. Mier, A. Gazdar, and R. C. Gallo, Human cutaneous T-cell lymphoma and leukemia cell lines produce and respond to T cell growth factor, J. Exp. Med. 154: 1403 (1981).PubMedCrossRefGoogle Scholar
  11. 11.
    T. Uchiyama, J. Yodoi, K. Sakawa, K. Takatsuki, and H. Uchino, Adult T cell leukemia: Clinical and hematologic features of 16 cases, Blood 50: 481 (1977).PubMedGoogle Scholar
  12. 12.
    B. J. Poiesz, F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, and R. C. Gallo, Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T cell lymphoma, Proc. Natl. Acad. Sci. USA 77: 7415 (1980).PubMedCrossRefGoogle Scholar
  13. 13.
    B. A. Brigham, P. A. Bunn, J. E. Horton, G. P. Schechter, L. M. Wahl, E. C. Bradley, N. R. Dunnick, and M. J. Matthews, Skeletal manifestations in cutaneous T cell lymphomas, Arch. Dermatol. 118: 461 (1982).PubMedCrossRefGoogle Scholar
  14. 14.
    M. S. Reitz, B. J. Poiesz, F. W. Ruscetti, and R. C. Gallo, Characterization and distribution of nucleic acid sequences of a novel type C retrovirus isolated from neoplastic human T lymphocytes, Proc. Natl. Acad. Sci. USA 78: 1187 (1981).CrossRefGoogle Scholar
  15. 15.
    V. S. Kalyanaraman, M. G. Sarngadharan, B. J. Poiesz, F. W. Ruscetti, and R. C. Gallo, Immunologic properties of a type C retrovirus isolated from a cultured human T-lymphoma cells and comparison to other mammalian retroviruses, J. Virol. 38: 906 (1981).PubMedGoogle Scholar
  16. 16.
    M. Robert-Guroff, F. W. Ruscetti, L. E. Posner, B. J. Poiesz, and R. C. Gallo, Detection of the human T-cell lymphoma virus p19 in cells of some patients with cutaneous T cell lymphoma and leukemia using a monoclonal antibody, J. Exp. Med. 154:1957 (1PubMedCrossRefGoogle Scholar
  17. 17.
    H. M. Rho, B. J. Poiesz, F. W. Ruscetti, and R. C. Gallo, Characterization of the reverse transcriptase from a new retrovirus (HTLV) produced by a human cutaneous T cell lymphoma cell line, Virology 112: 355 (1981).PubMedCrossRefGoogle Scholar
  18. 18.
    K. Tajima, S. Tominaga, T. Kuroishi, H. Shimizu, and T. Suchi, Geographical features and epidemiological approach to endemic T cell leukemia/lymphoma in Japan, Jpn. J. Clin. Oncol. 9 (suppl): 495 (1979).Google Scholar
  19. 19.
    R. C. Gallo, G. B. deThe, and Y. Ito, Kyoto Workshop on some specific recent advances in human tumor virology. (Meeting report), Cancer Res. 41: 4738 (1981).PubMedGoogle Scholar
  20. 20.
    M. Popovic, M. S. Reitz, M. G. Sarngadharan, M. Robert-Guroff, V. S. Kalyanaraman, Y. Nakao, I. Miyoshi, J. Minowada, M. Yoshida, Y. Ito, and R. C. Gallo, The virus of Japanese adult T cell leukaemia is a member of the human T cell leukaemia virus group, Nature 300: 63 (1982).PubMedCrossRefGoogle Scholar
  21. 21.
    D. Catovsky, M. F. Greaves, M. Rose, D. A. G. Galton, A. W. G. Goolden, D. R. McCluskey, J. M. White, I. Lampert, G. Bourikas, R. Ireland, J. M. Bridges, W. A. Blattner, and R. C. Gallo, Adult T cell lymphoma-leukemia in Blacks the West Indies, Lancet I: 639 (1982).CrossRefGoogle Scholar
  22. 22.
    W. A. Blattner, V. S. Kalyanaraman, M. Robert-Guroff, T. A. Lister, D. A. G. Galton, P. Sarin, M. H. Crawford, D. Catovsky, M. F. Greaves, and R. C. Gallo, The human type C retrovirus, HTLV, in Blacks from the Caribbean region and relationship to adult T-cell leukemia/lymphoma, Int. J. Cancer 30:257 (1982).Google Scholar
  23. 23.
    W. A. Blattner, D. W. Blayney, M. Robert-Guroff, M. G. Sarngadharan, V. S. Kalyanaraman, P. S. Sarin, E. S. Jaffe, and R. C. Gallo, Epidemiology of the human T cell leukemia/ lymphoma virus (HTLV), J. Infect. Dis. 147: 406 (1983).PubMedCrossRefGoogle Scholar
  24. 24.
    D. W. Blayney, E. S. Jaffe, W. A. Blattner, J. Cossman, M. Robert-Guroff, D. L. Longo, P. A. Bunn, and R. C. Gallo, The human T-cell leukemia/lymphoma virus) HTLV defines a distinct clinical entity, Blood 62: 401 (1983).PubMedGoogle Scholar
  25. 25.
    R. C. Gallo, D. Mann, S. Broder, F. W. Ruscetti, M. Maeda, V. S. Kalyanaraman, M. Robert-Guroff, and M. S. Reitz, Human T-cell leukemia-lymphoma virus (HTLV) is in T- but not B-lymphocytes from a patient with cutaneous T-cell lymphoma, Proc. Natl. Acad. Sci. USA 79: 5680 (1982).PubMedCrossRefGoogle Scholar
  26. 26.
    R. C. Gallo and F. Wong-Staal, Retroviruses as etiologic agents of some animal and human leukemias and lymphomas and as tools for elucidating the molecular mechanism of leukemogenesis, Blood 60: 545 (1982).PubMedGoogle Scholar
  27. 27.
    J. Vieira, E. Frank, T. J. Spira, and S. H. Landesman, Acquired immunodeficiency in Haitians: Opportunistic infections in previously healthy Haitian immigrants, N. Engl. J. Med. 308: 125 (1983).PubMedCrossRefGoogle Scholar
  28. 28.
    D. Mildvan, V. Mathur, R. W. Enlow, P. L. Romain, R. J. Winchester, C. Colp, H. Singman, B. R. Adelsberg, and I. Spigland, Opportunistic infections and immune deficiency in homosexual men, Ann. Int. Med. 96: 700 (1982).PubMedGoogle Scholar
  29. 29.
    M. Essex, M. F. McLane, T. H. Lee, L. Falk, C. W. S. Howe, J. I. Mullins, C. Cabradilla, and P. P. Francis, Antibodies to cell membrane antigens associated with human T-cell leukemia virus in patients with AIDS, Science 220: 859 (1983).PubMedCrossRefGoogle Scholar
  30. 30.
    E. P. Gelmann, M. Popovic, D. Blayney, H. Masur, G. Sidhu, R. H. Stahl, and R. C. Gallo, Proviral DNA of a retrovirus, human T-cell leukemia virus, in two patients with AIDS, Science 220: 862 (1983).PubMedCrossRefGoogle Scholar
  31. 31.
    R. C. Gallo, P. S. Sarin, E. P. Gelmann, M. Robert-Guroff, E. Richardson, V. S. Kalyanaraman, D. Mann, G. D. Sidhu, R. E. Stahl, S. Zolla-Pazner, J. Leibowitch, and M. Popovic, Isolation of a human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS), Science 220: 865 (1983).PubMedCrossRefGoogle Scholar
  32. 32.
    M. Essex, M. F. McLane, T. H. Lee, T. Jachibana, J. I. Mullins, J. Kreiss, C. K. Kasper, M. C. Poon, S. Landay, S. F. Stein, D. P. Francis, C. Cabradilla, D. N. Lawrence, and B. L. Evatt, Antibodies to human T-cell leukemia virus membrane antigens (HTLV-MA) in hemophiliacs, Science 221: 1061 (1983).PubMedCrossRefGoogle Scholar
  33. 33.
    P. A. Bunn, G. P. Schechter, E. Jaffe, D. Blayney, R. C. Young, M. J. Matthews, W. Blattner, S. Broder, M. Robert-Guroff, and R. C. Gallo, Clinical course of retrovirus-associated adult T cell lymphoma in the United States, N. Engl. J. Med 309: 257 (1983).PubMedCrossRefGoogle Scholar
  34. 34.
    M. Matsumoto, K. Nomuía, T. Matsumoto, K. Nishioka, S. Hanada, H. Furusho, H. Kikuchi, Y. Kato, A. Utsunomiya, T. Uematsu, M. Iwahashi, S. Hashimoto, and K. Ydenoki, K., Adult T-cell leukemia-lymphoma in Kagoshima District, Southwestern Japan: Clinical and hematological characteristics, Jpn. J. Clin. Oncol. 9 (suppl): 325 (1979).Google Scholar
  35. 35.
    Lymphoma Study Group, Combination chemotherapy with vincristine, cyclophosphamide (Endoxan), prednisolone, and adriamycin (VEPA) in advanced adult non-Hodgkin’s lymphoid malignancies: Relation between T-cell and non-T-cell phenotype and response, Jpn. J. Clin. Oncol. 9 (suppl): 397 (1979).Google Scholar
  36. 36.
    R. I. Fisher, V. T. DeVita, Jr., S. M., Hubbard, D. L., Longo, R. L. Wesley, B. A. Chabner, and R. C. Young, Diffuse aggressive lymphomas: Increased survival after alternating flexible sequences of ProMACE and MOPP chemotherapy, Ann. Int. Med 98: 304 (1983).Google Scholar
  37. 37.
    L. M. Nadler, M. Stashenko, R. Hardy, W. D. Kaplan, L. N. Button, D. W. Kufe, K. H. Antman, and S. F. Schlossman, Serotherapy of a patient with a monoclonal antibody directed against a human lympohoma-associated antigen, Cancer Res. 40: 3147 (1980).PubMedGoogle Scholar
  38. 38.
    R. A. Miller, D. G. Maloney, J. McKillop, and R. Levy, In vivo effects of murine hybridoma monoclonal antibody in a patient with T cell leukemia, Blood 58:78 (1981).PubMedGoogle Scholar
  39. 39.
    J. Ritz, J. M. Pesando, S. E. Sallan, L. A. Clavell, J. Notis-McConarty, R. Rosenthal, and S. F. Schlossman, Serotherapy of acute lymphoblastic leukemia with monoclonal antibody, Blood 58: 141 (1981).PubMedGoogle Scholar
  40. 40.
    R. A. Miller and R. Levy, Response of cutaneous T cell lymphoma to therapy with hybridoma monoclonal antibody, Lancet II: 226 (1981).CrossRefGoogle Scholar
  41. 41.
    C. K. Grant, F. de Noronha, C. Tusch, M. T. Michalek, and M. F. McLane, Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells, J. Natl. Cancer Inst. 65: 1285 (1980).PubMedGoogle Scholar
  42. 42.
    B. F. Haynes, M. Robert-Guroff, R. S. Metygar, G. Franchini, V. S. Kalyanaraman, T. J. Palker, and R. C. Gallo, Monoclonal antibody against human T cell leukemia virus p19 defines a human thymic epithelial antigen acquired during ontogeny, J. Exp. Med. 157: 907 (1983).PubMedCrossRefGoogle Scholar
  43. 43.
    M. F. Clarke, E. P. Gelmann, and M. S. Reitz, Jr., Homology of human T-cell leukemia virus envelope gene with class I HLA gene, Nature 305: 60 (1983).PubMedCrossRefGoogle Scholar
  44. 44.
    D. L. Mann, M. Popovic, P. Sarin, C. Murray, M. S. Reitz, D. M. Strong, B. F. Haynes, R. C. Gallo, and W. A. Blattner, Cell lines producing human T-cell lymphoma virus show altered HLA expression, Nature 305: 58 (1983).PubMedCrossRefGoogle Scholar
  45. 45.
    Z. Lando, P. Sarin, M. Megson, W. L. Greene, T. A. Waldmann, R. C. Gallo, and S. Broder, Association of human T-cell leukemia/lymphoma virus (HTLV) with the Tac antigen-marker for the receptor T-cell growth factor, Nature in press (1983).Google Scholar
  46. 46.
    H. Mitsuya, L. A. Matis, M. Megson, P. A. Bunn, C. Murray, D. L. Mann, R. C. Gallo, and S. Broder, Generation of an HLA-restricted cytotoxic T-cell line reactive against cultured tumor cells from a patient infected with human T-cell leukemia/lymphoma virus (HTLV), J. Exp. Med. 158: 994 (1983).PubMedCrossRefGoogle Scholar
  47. 47.
    H. Tsuda and K. Takatsuki, Adult T-cell leukemia cells expressing OKT 17 antigen in the activated state, Hematological Oncology 1: 263 (1983).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • Hiroaki Mitsuya
    • 1
  • Samuel Broder
    • 1
  1. 1.Clinical Oncology ProgramMational Cancer InstituteBethesdaUSA

Personalised recommendations